These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9051645)

  • 1. Evaluation of a vaginal moisturizer in baboons with decreasing ovarian function.
    Hubbard GB; Carey KD; Levine H; Bachmann GA
    Lab Anim Sci; 1997 Feb; 47(1):36-9. PubMed ID: 9051645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of raloxifene on sexual function in postmenopausal women.
    Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
    Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrophic vaginitis.
    Stika CS
    Dermatol Ther; 2010; 23(5):514-22. PubMed ID: 20868405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study: Replens versus local estrogen in menopausal women.
    Nachtigall LE
    Fertil Steril; 1994 Jan; 61(1):178-80. PubMed ID: 8293835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal toxicity studies of a gel formulation of native pokeweed antiviral protein.
    D'Cruz OJ; Waurzyniak B; Uckun FM
    Toxicol Pathol; 2004; 32(2):212-21. PubMed ID: 15200159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
    Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing postmenopausal vaginal atrophy. Vaginal dryness is one of the most irritating symptoms of menopause. Here are some ways to relieve it.
    Harv Womens Health Watch; 2010 Mar; 17(7):4-5. PubMed ID: 20480969
    [No Abstract]   [Full Text] [Related]  

  • 9. Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy.
    Morali G; Polatti F; Metelitsa EN; Mascarucci P; Magnani P; Marrè GB
    Arzneimittelforschung; 2006; 56(3):230-8. PubMed ID: 16618016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of vaginal suppositories for the treatment of the vaginal atrophy in postmenopausal women: an open, non-controlled clinical trial.
    Costantino D; Guaraldi C
    Eur Rev Med Pharmacol Sci; 2008; 12(6):411-6. PubMed ID: 19146203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety studies of a recently developed microbicidal contraceptive gel (UniPron) in female baboons (Papio anubis).
    Mburu N; Obiero JA; Waititu K; Mwaura BN; Orawo JO; Farah IO; Mwethera PG
    Afr J Reprod Health; 2009 Dec; 13(4):95-104. PubMed ID: 20690277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.
    Crandall C
    J Womens Health (Larchmt); 2002 Dec; 11(10):857-77. PubMed ID: 12626086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evaluation of the local tolerance of vaginal formulations containing dapivirine using the Slug Mucosal Irritation test and the rabbit vaginal irritation test.
    Dhondt MM; Adriaens E; Roey JV; Remon JP
    Eur J Pharm Biopharm; 2005 Aug; 60(3):419-25. PubMed ID: 15996583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of post-menopausal vaginal atrophy and atrophic vaginitis.
    Castelo-Branco C; Cancelo MJ; Villero J; Nohales F; Juliá MD
    Maturitas; 2005 Nov; 52 Suppl 1():S46-52. PubMed ID: 16139449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
    Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
    Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the estrogenic potential of two synthetic estrogens (mestranol and ethinylestradiol).
    Teter J; Stupnicki R
    Acta Cytol; 1971; 15(2):167-70. PubMed ID: 5282948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study.
    Biglia N; Peano E; Sgandurra P; Moggio G; Panuccio E; Migliardi M; Ravarino N; Ponzone R; Sismondi P
    Gynecol Endocrinol; 2010 Jun; 26(6):404-12. PubMed ID: 20196634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women.
    Goldstein I; Alexander JL
    J Sex Med; 2005 Sep; 2 Suppl 3():154-65. PubMed ID: 16422792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.